|
2024
|
Invention
|
Compositions and methods for inhibiting the proliferation of pathogenic escherichia coli.
A comp... |
|
2023
|
Invention
|
Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis... |
|
|
Invention
|
Bacteroides fragilis. Bacteroides fragilis cells by the Siphoviridae bacteriophage. |
|
|
Invention
|
Antimicrobial protein cdl2200 having lytic activity to clostridioides difficile. Clostridioidesdi... |
|
|
Invention
|
Antibacterial protein having strong lytic activity to staphylococci including staphylococcus aure... |
|
|
Invention
|
Composition of antibacterial protein for treating bovine mastitis. Staphylococcusaureusaureus. Mo... |
|
|
Invention
|
Antibacterial protein having lytic activity against streptococci. The present invention relates t... |
|
|
Invention
|
Antibacterial protein composition for treatment of bovine mastitis. The present invention relates... |
|
2022
|
Invention
|
Genetic element e3 for enhanced intracellular expression of target protein encoded in rna therape... |
|
|
Invention
|
Antibacterial composition effective in treating gram negative bacterial infections and method for... |
|
|
G/S
|
Research and development relating to drug substance and drug products for the pharmaceutical, bio... |
|
|
Invention
|
Mucosal messenger rna vaccine.
The present invention is related to a mucosal mRNA vaccine. More ... |
|
|
Invention
|
Mucosal messenger rna vaccine. The present invention is related to a mucosal mRNA vaccine. More s... |
|
|
Invention
|
Alternative novel material to botulinum neurotoxin and preparation method thereof.
Described is ... |
|
|
Invention
|
Alternative novel material to botulinum neurotoxin and preparation method therefor. The present i... |
|
|
G/S
|
Pharmaceutical products for the prevention of infectious diseases; Sanitizing preparations for ho... |
|
2021
|
Invention
|
Antibacterial protein efl200 having lytic activity to enterococcus faecium. Enterococcusfaeciumfa... |
|
|
Invention
|
Escherichia coli. A composition for preventing or treating an infection or disease caused by a pa... |
|
|
G/S
|
research and development relating to drug substance and drug products for the pharmaceutical, bio... |
|
|
Invention
|
Compositions and methods for inhibiting the proliferation of pathogenic escherichia coli. A compo... |
|
|
Invention
|
Antibacterial protein having lytic activity against clostridioides difficile. Clostridioidesdiffi... |
|
|
Invention
|
Antibacterial substance having lytic activity against actinobacillus pleuropneumoniae and method ... |
|
|
Invention
|
Compositions and methods for inhibiting the proliferation of pathogenic escherichia coli. Escheri... |
|
|
Invention
|
Antibacterial protein cdl200 having lytic activity against clostridioides difficile.
The present... |
|
|
Invention
|
Antibacterial protein cdl200 having lytic activity against clostridioides difficile. Clostridioid... |
|
|
Invention
|
Bacillus genus and method for preparing the same. Bacillus. The method includes: culturing BL21-p... |
|
|
Invention
|
Antibacterial protein having lytic activity to bacillus genus and method for preparing the same. ... |
|
|
Invention
|
Freeze-dried formulations of antibacterial protein.
A freeze-dried formulation includes an antib... |
|
|
Invention
|
A method for preparing porcine myoglobin using escherichia coli.
A method for preparing a porcin... |
|
|
Invention
|
Method for preparing soy leghemoglobin using escherichia coli.
A method for preparing a soy legh... |
|
|
Invention
|
A method for preparing bovine myoglobin using escherichia coli.
A method for preparing a bovine ... |
|
|
Invention
|
Escherichia coli. Bos taurusEscherichia coliEscherichia coliEscherichia coli production host. A c... |
|
|
Invention
|
Escherichia coli. Sus scrofaEscherichia coliEscherichia coliEscherichia coli production host. A c... |
|
|
Invention
|
Escherichia coli. Escherichia coliEscherichia coliEscherichia coli production host. A composition... |
|
2020
|
Invention
|
Escherichia coli . Escherichia coli by the Podoviridae bacteriophage. |
|
|
Invention
|
Escherichia coli. Escherichia coli by the Myoviridae bacteriophage. |
|
2019
|
Invention
|
E. coli bacteriophage esc-cop-14 and use thereof in inhibiting growth of pathogenic e. coli.
The... |
|
|
Invention
|
Novel streptococcus suis bacteriophage str-sup-1 and use thereof in inhibiting streptococcus suis... |
|
2017
|
Invention
|
Lactococcus garvieae bacteria. Lactococcus garvieae bacterial infection by using a composition co... |
|
2016
|
G/S
|
Pharmaceutical products for the treatment of infectious diseases; sanitizing preparations for hos... |
|
2015
|
G/S
|
diagnostic test reagents for medical or veterinary purposes; medical diagnostic test strips for i... |
|
2012
|
G/S
|
Chemical, biochemical and biotechnological agents for industrial and scientific purposes, namely ... |
